IP Library Granted Patent US 7,803,369
Granted Patent B2
US 7,803,369 · App. 11/192,542 · Granted Sep 28, 2010

Devices and method for repair of larynx, trachea, and other fibrocartilaginous tissues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,803,369
App. No.
11/192,542
Granted
Sep 28, 2010
Kind
B2
Abstract

Provided herein are methods and devices for inducing the formation of functional replacement nonarticular cartilage tissues and ligament tissues. These methods and devices involve the use of osteogenic proteins, and are useful in repairing defects in the larynx, trachea, interarticular menisci, intervertebral discs, ear, nose, ribs and other fibrocartilaginous tissues in a mammal.

Claims (7)

1. An implantable device for repairing a defect in a nonarticular cartilage tissue of a mammal, the device consisting essentially of an osteogenic protein disposed in a devitalized cartilage, wherein the osteogenic protein is selected from the group consisting of osteogenic protein (OP)-1, OP-2, OP-3, bone morphogenetic protein (BMP)-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-9, BMP-10, BMP-11, BMP-15, BMP-3B, decapentaplegic (DPP), vegetal -1 (Vg-1), vegetal-related-1 (Vgr-1), and 60A protein.

2. The device of claim 1 , wherein the devitalized cartilage is an autologous cartilage or an allogenic cartilage.

3. The device of claim 1 , wherein the osteogenic protein is OP-1.

4. The device of claim 3 , wherein the devitalized cartilage is an allogenic cartilage.

5. An implantable device for repairing a defect in a nonarticular cartilage tissue of a mammal, the device consisting essentially of an osteogenic protein disposed in a carboxymethylcellulose carrier.

6. The device of claim 5 , wherein the osteogenic protein is op-1.

7. The device of claim 5 , wherein the carrier further comprises allogenic or autologous blood.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2016
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 037460/0806 →
LIEN Recorded Jan 8, 2016
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 037461/0778 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2014
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 033535/0440 →